Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe induction treatment options prior to autologous stem cell transplantation
- Discuss first-line treatment options for patients with renal insufficiency
- Relate the effective management of bortezomib-induced peripheral neuropathy
- Summarize options for therapy for multiple myeloma patients following autologous stem cell transplantation
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.